Information for investors

The company calls for additional investors

Medicortex Finland Plc is giving current shareholders as well as new investors the opportunity to invest in the company and be part of tackling a worldwide problem - the silent epidemic of Traumatic Brain Injury. By investing, shareholders will enable development of an innovative diagnostic kit and are simultaneously given an opportunity for financial gain. By investing in Medicortex one becomes a partner in the company as well as contributing to a social need. 

The company's shares can be subscribed at the price of 0,74 Euro per share. Additional information as well as the company’s slideshow presentation, executive summary, and a subscription agreement are available here, on our website. 

Information for investors

1. Why invest
   
2. How the Medicortex test kit would benefit people
   
3. Get to know more by viewing our PowerPoint Presentation and Executive summary
4. Here you can find our Financials
   
   
   
   

Get the latest investor updates in your inbox

Sign up to Medicortex email list. 

Note: This information may not be published or distributed directly or indirectly in the United States, Australia, Canada, Hong Kong, South Africa, Singapore, New Zealand, Japan or in any other country where disclosure or dissemination would be unlawful.

Investments always include risks. Invest responsibly!